These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 19537345)

  • 1. Cardiorenal metabolic syndrome in the African diaspora: rationale for including chronic kidney disease in the metabolic syndrome definition.
    Lea JP; Greene EL; Nicholas SB; Agodoa L; Norris KC
    Ethn Dis; 2009; 19(2 Suppl 2):S2-11-14. PubMed ID: 19537345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic Syndrome Severity and Risk of CKD and Worsened GFR: The Jackson Heart Study.
    DeBoer MD; Filipp SL; Musani SK; Sims M; Okusa MD; Gurka M
    Kidney Blood Press Res; 2018; 43(2):555-567. PubMed ID: 29642060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic syndrome, proteinuria, and the risk of progressive CKD in hypertensive African Americans.
    Lea J; Cheek D; Thornley-Brown D; Appel L; Agodoa L; Contreras G; Gassman J; Lash J; Miller ER; Randall O; Wang X; McClellan W;
    Am J Kidney Dis; 2008 May; 51(5):732-40. PubMed ID: 18436083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial differences in kidney function among individuals with obesity and metabolic syndrome: results from the Kidney Early Evaluation Program (KEEP).
    Bomback AS; Kshirsagar AV; Whaley-Connell AT; Chen SC; Li S; Klemmer PJ; McCullough PA; Bakris GL
    Am J Kidney Dis; 2010 Mar; 55(3 Suppl 2):S4-S14. PubMed ID: 20172446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic syndrome in Black people of the African diaspora: the paradox of current classification, definition and criteria.
    Gaillard T; Schuster D; Osei K
    Ethn Dis; 2009; 19(2 Suppl 2):S2-1-7. PubMed ID: 19537240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between GFR and risk factors for morbidity and mortality in African Americans with CKD.
    Erickson KF; Lea J; McClellan WM
    Clin J Am Soc Nephrol; 2013 Jan; 8(1):75-81. PubMed ID: 23085727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity and synergistic risk factors for chronic kidney disease in African American adults: the Jackson Heart Study.
    Olivo RE; Davenport CA; Diamantidis CJ; Bhavsar NA; Tyson CC; Hall R; Bidulescu A; Young B; Mwasongwe SE; Pendergast J; Boulware LE; Scialla JJ
    Nephrol Dial Transplant; 2018 Jun; 33(6):992-1001. PubMed ID: 28992354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic syndrome but not obesity measures are risk factors for accelerated age-related glomerular filtration rate decline in the general population.
    Stefansson VTN; Schei J; Solbu MD; Jenssen TG; Melsom T; Eriksen BO
    Kidney Int; 2018 May; 93(5):1183-1190. PubMed ID: 29395334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of end-stage renal disease from chronic kidney disease defined by decreased glomerular filtration rate in type 1 diabetes: A comparison with type 2 diabetes and the effect of metabolic syndrome.
    Lee YB; Han K; Kim B; Jun JE; Lee SE; Ahn J; Kim G; Jin SM; Kim JH
    Diabetes Metab Res Rev; 2019 Nov; 35(8):e3197. PubMed ID: 31222888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic syndrome in nondiabetic, obese, first-degree relatives of African American patients with type 2 diabetes: African American triglycerides-HDL-C and insulin resistance paradox.
    Meis SB; Schuster D; Gaillard T; Osei K
    Ethn Dis; 2006; 16(4):830-6. PubMed ID: 17061734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular Outcomes in African Americans with Sickle Cell Trait and Chronic Kidney Disease.
    Olaniran KO; Eneanya ND; Allegretti AS; Zhao SH; Achebe MM; Thadhani RI
    Am J Nephrol; 2019; 49(2):93-102. PubMed ID: 30625463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of proteinuria with race, cause of chronic kidney disease, and glomerular filtration rate in the chronic kidney disease in children study.
    Wong CS; Pierce CB; Cole SR; Warady BA; Mak RH; Benador NM; Kaskel F; Furth SL; Schwartz GJ;
    Clin J Am Soc Nephrol; 2009 Apr; 4(4):812-9. PubMed ID: 19297612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Race and sex differences in hypertension control in CKD: results from the Kidney Early Evaluation Program (KEEP).
    Duru OK; Li S; Jurkovitz C; Bakris G; Brown W; Chen SC; Collins A; Klag M; McCullough PA; McGill J; Narva A; Pergola P; Singh A; Norris K
    Am J Kidney Dis; 2008 Feb; 51(2):192-8. PubMed ID: 18215697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of cardiovascular disease in kidney donors as a chronic kidney disease cohort.
    Naganuma T; Takemoto Y; Taiyou O; Hirokazu T; Masaki M; Maeda S; Nakatani T
    Mol Med Rep; 2012 Jan; 5(1):7-11. PubMed ID: 21993905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic syndrome and risk of progression of chronic kidney disease: a single-center cohort study in Japan.
    Saito T; Mochizuki T; Uchida K; Tsuchiya K; Nitta K
    Heart Vessels; 2013 May; 28(3):323-9. PubMed ID: 22526382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic kidney disease incidence, and progression to end-stage renal disease, in HIV-infected individuals: a tale of two races.
    Lucas GM; Lau B; Atta MG; Fine DM; Keruly J; Moore RD
    J Infect Dis; 2008 Jun; 197(11):1548-57. PubMed ID: 18422458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of measured GFR, serum creatinine, cystatin C, and beta-trace protein to predict ESRD in African Americans with hypertensive CKD.
    Bhavsar NA; Appel LJ; Kusek JW; Contreras G; Bakris G; Coresh J; Astor BC;
    Am J Kidney Dis; 2011 Dec; 58(6):886-93. PubMed ID: 21944667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subclinical Kidney Damage in Hypertensive Patients: A Renal Window Opened on the Cardiovascular System. Focus on Microalbuminuria.
    Mulè G; Castiglia A; Cusumano C; Scaduto E; Geraci G; Altieri D; Di Natale E; Cacciatore O; Cerasola G; Cottone S
    Adv Exp Med Biol; 2017; 956():279-306. PubMed ID: 27873229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of modifiable chronic kidney disease risk factors by gender in an African-American metabolic syndrome cohort.
    Brown LJ; Clark PC; Armstrong KA; Liping Z; Dunbar SB
    Nephrol Nurs J; 2010; 37(2):133-41, 148; quiz 142. PubMed ID: 20462073
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.